Author:
Ghaemi S. Nassir,Hsu Douglas J.,Rosenquist Klara J.,Pardo Tamara B.,Goodwin Frederick K.
Subject
Biological Psychiatry,Pharmacology
Reference20 articles.
1. The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting;Ascher-Svanum;Am. J. Manag. Care,2004
2. Olanzapine vs. Haloperidol in the treatment of elderly chronic schizophrenia patients;Barak;Prog. Neuropsychopharmacol. Biol. Psychiatry,2002
3. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine;Carlson;J. Clin. Psychiatry,2003
4. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (ic-soho) comparing olanzapine, quetiapine, risperidone, and haloperidol;Dossenbach;J. Clin. Psychiatry,2004
5. Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study);Garcia-Cabeza;BMC Psychiatry,2001
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献